BIIB vs KO · P/E 21, rev $9.89B vs P/E 25, rev $47.94B
Biogen Inc (BIIB) versus The Coca-Cola Company (KO) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Not investment advice. Open the BIIB and KO stock pages for the full models.
Not investment advice.